Phil Grayeski, PhD, is a Managing Partner at KdT Ventures who joined in 2018. He has been instrumental in spinning out three biotechnology companies.
At firms with a similar stage, sector and check size.
One email when Phil's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckPhil Grayeski, PhD, is a Managing Partner at KdT Ventures who joined in 2018. He has been instrumental in spinning out three biotechnology companies.
Phil Grayeski invests through KdT Ventures, which writes checks of $500K to $10M at pre-seed, seed, series a.
A warm intro from a founder KdT Ventures backed works best.
founder at Torque Bio; founder at StrideBio; founder at Ribometrix.
Last updated 2026-10-15. Is this you? Ask for a correction.